155 related articles for article (PubMed ID: 18700609)
1. Vasospasm and stroke attributable to ephedra-free xenadrine: case report.
Holmes RO; Tavee J
Mil Med; 2008 Jul; 173(7):708-10. PubMed ID: 18700609
[TBL] [Abstract][Full Text] [Related]
2. Coronary thrombosis related to use of Xenadrine RFA.
Sachdeva R; Sivasankaran S; Fishman RF; Zarich SW; McPherson CA
Tex Heart Inst J; 2005; 32(1):74-7. PubMed ID: 15902827
[TBL] [Abstract][Full Text] [Related]
3. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine.
Bouchard NC; Howland MA; Greller HA; Hoffman RS; Nelson LS
Mayo Clin Proc; 2005 Apr; 80(4):541-5. PubMed ID: 15819293
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of ephedra-free weight-loss supplements in humans.
Haller CA; Benowitz NL; Jacob P
Am J Med; 2005 Sep; 118(9):998-1003. PubMed ID: 16164886
[TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic effects of a dietary supplement containing ephedra and caffeine.
Milic M; Rizos D; Ziegler MG
JAMA; 2005 Sep; 294(12):1487; author reply 1487-8. PubMed ID: 16189358
[No Abstract] [Full Text] [Related]
6. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial.
McBride BF; Karapanos AK; Krudysz A; Kluger J; Coleman CI; White CM
JAMA; 2004 Jan; 291(2):216-21. PubMed ID: 14722148
[TBL] [Abstract][Full Text] [Related]
7. More evidence supporting the ban of ephedra dietary supplements.
Chavez ML
Ann Pharmacother; 2004 May; 38(5):895-7. PubMed ID: 15044656
[No Abstract] [Full Text] [Related]
8. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations.
Haller CA; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2005 Jun; 77(6):560-71. PubMed ID: 15961987
[TBL] [Abstract][Full Text] [Related]
9. Hypertensive Urgency Associated With Xenadrine EFX Use.
Moaddeb J; Tofade TS; Bevins MB
J Pharm Pract; 2011 Jun; ():. PubMed ID: 21676849
[TBL] [Abstract][Full Text] [Related]
10. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature.
Thomas JE; Munir JA; McIntyre PZ; Ferguson MA
Tex Heart Inst J; 2009; 36(6):586-90. PubMed ID: 20069086
[TBL] [Abstract][Full Text] [Related]
11. Use of Ephedra-containing products and risk for hemorrhagic stroke.
Morgenstern LB; Viscoli CM; Kernan WN; Brass LM; Broderick JP; Feldmann E; Wilterdink JL; Brott T; Horwitz RI
Neurology; 2003 Jan; 60(1):132-5. PubMed ID: 12525737
[TBL] [Abstract][Full Text] [Related]
12. Ischemic stroke after using over the counter products containing ephedra.
Chen C; Biller J; Willing SJ; Lopez AM
J Neurol Sci; 2004 Jan; 217(1):55-60. PubMed ID: 14675610
[TBL] [Abstract][Full Text] [Related]
13. Ephedra-free is not danger-free.
Marcus DM; Grollman AP
Science; 2003 Sep; 301(5640):1669-71; author reply 1669-71. PubMed ID: 14500960
[No Abstract] [Full Text] [Related]
14. JAMA patient page. Ephedra and ephedrine.
Torpy JM; Lynm C; Glass RM
JAMA; 2003 Mar; 289(12):1590. PubMed ID: 12672776
[No Abstract] [Full Text] [Related]
15. The relative safety of ephedra compared with other herbal products.
Kalman DS; Antonio J; Kreider RB
Ann Intern Med; 2003 Jun; 138(12):1006; author reply 1006-7. PubMed ID: 12809464
[No Abstract] [Full Text] [Related]
16. Cardiovascular effects of ephedra.
Ness J
JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069037
[No Abstract] [Full Text] [Related]
17. Cardiovascular effects of ephedra.
Krantz MJ
JAMA; 2004 Apr; 291(13):1560; author reply 1560-1. PubMed ID: 15069036
[No Abstract] [Full Text] [Related]
18. Evaluation of the stimulant content of dietary supplements marketed as "ephedra-free".
Gregory PJ
J Herb Pharmacother; 2007; 7(1):65-72. PubMed ID: 17594988
[TBL] [Abstract][Full Text] [Related]
19. Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy.
Gurley BJ; Steelman SC; Thomas SL
Clin Ther; 2015 Feb; 37(2):275-301. PubMed ID: 25262198
[TBL] [Abstract][Full Text] [Related]
20. Vasospasm-induced stroke in a varsity athlete secondary to ephedrine ingestion.
Foxford RJ; Sahlas DJ; Wingfield KA
Clin J Sport Med; 2003 May; 13(3):183-5. PubMed ID: 12792214
[No Abstract] [Full Text] [Related]
[Next] [New Search]
